Skip to main content
OpenTrials
Completed

NCT Number: NCT02220686

Vascular Physician Offer and Report (VAPOR) Trial

The purpose of the study is to see if vascular physicians (your provider) using a combination of proven smoking cessation tools in an organized way can help vascular patients quit smoking better than usual.

The doctors where you are being treated have been chosen to either provide:

the combination therapy of giving you advice, considering prescribing medications to help you quit smoking, and referring you to a phone quitline, or to continue their usual smoking cessation practices (which may include all, some, or none of the treatments above).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Peripheral Artery Disease (PAD) Arterial Occlusive Diseases Arteriosclerosis Atherosclerosis Behavior Cardiovascular Diseases Health Behavior Peripheral Arterial Disease Peripheral Vascular Diseases Smoking Cessation Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UF Health, Gainesville, Florida, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age >18
  • Current smoker
  • Plan to have a Vascular Quality Initiative (VQI) procedure in > 7 days

Exclusion criteria

  • Pregnant Women, Fetuses and Neonates
  • Children
  • People with impaired decision-making capacity

Treatment and study plan

Offer and Report Protocol

Behavioral

Physician advice to stop smoking, referral to state Quitline, and physician considers prescribing nicotine replacement therapy.

Primary outcomes

  1. Efficacy of the "Offer and Report" protocol for change in smoking status from Baseline Visit to 3 Month Visit

    Time frame: Change in smoking status from Baseline Visit to 3 Month Visit

    To assess the efficacy of the "Offer and Report" protocol (standardized (1) "very brief advice," (2) referral to telephone-based smoking cessation counseling, and (3) consideration of prescribing nicotine replacement therapy (NRT)) as compared to usual smoking cessation care by vascular physicians in biochemically-validated 3 month smoking cessation rates. A questionnaire will be completed by the patient at the Baseline visit and another questionnaire will be completed at the 3 month visit to assess the change in smoking status.

Sponsors and collaborators

Lead sponsor

Dartmouth-Hitchcock Medical Center

Other

Collaborators

  • Society for Vascular Surgery

Registry information

Acronym: VAPOR

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Aug 20, 2014
Registry last updated
Jul 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.